Jan Lundberg

Jan M.
Lundberg is the founder of Aerocrine AB. Current jobs include Director at Metabolon, Inc. since 2019; Director at Biotechnology Innovation Organization; Director at Ferring Pharmaceuticals, Inc.; Director at PhRMA Foundation; Director at Betagenon Sweden AB since 2019; Director at Transcelerate Biopharma, Inc.; Director at Anocca AB; Independent Director at AlzeCure Pharma AB since 2024; and Advisory Board member at Accelerator Services Corp.
Former jobs include Director at Global Alliance for TB Drug Development; Director at Betagenon AB; Director at Pumped Hydro Storage Sweden AB; Independent Director at Ardelyx, Inc. from 2018 to 2024; Executive Vice President-Science & Technology at Eli Lilly & Co. from 2010 to 2018; Executive Vice President-Discovery Research at AstraZeneca PLC from 1999 to 2010; Head-Preclinical Research at Astra AB; Executive Vice President-Global Discovery Research at AstraZeneca AB; Professor at Karolinska Institutet; and President at Lilly Research Laboratories from 2010 to 2018.
Education includes doctorates from Karolinska Institutet and the University of Gothenburg.